Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 3526460, 5 pages
https://doi.org/10.1155/2017/3526460
Research Article

Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn’s Disease

1Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
2Hubei Clinical Center & Key Laboratory of Intestinal & Colorectal Diseases, Wuhan, China

Correspondence should be addressed to Qiu Zhao and Jin Li

Received 27 March 2017; Revised 16 May 2017; Accepted 31 May 2017; Published 17 July 2017

Academic Editor: Andrew S. Day

Copyright © 2017 Jue-Rong Feng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Baumgart and W. J. Sandborn, “Crohn’s disease,” Lancet, vol. 380, pp. 1590–1605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. B. Sartor, “Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis,” Nature Clinical Practice Gastroenterology & Hepatology, vol. 3, pp. 390–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Economou and G. Pappas, “New global map of Crohn’s disease: genetic environmental and socioeconomic correlations,” Inflammatory Bowel Diseases, vol. 14, pp. 709–720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. B. Menees, C. Powell, J. Kurlander, A. Goel, and W. D. Chey, “A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS,” The American Journal of Gastroenterology, vol. 110, pp. 444–454, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Agassandian, G. V. Shurin, Y. Ma, and M. R. Shurin, “C-reactive protein and lung diseases,” The International Journal of Biochemistry & Cell Biology, vol. 53, pp. 77–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kaptoge, E. Di Angelantonio, L. Pennells et al., “C-reactive protein, fibrinogen, and cardiovascular disease prediction,” The New England Journal of Medicine, vol. 367, pp. 1310–1320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Sipponen, P. Karkkainen, E. Savilahti et al., “Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings,” Alimentary Pharmacology & Therapeutics, vol. 28, pp. 1221–1229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Sipponen, E. Savilahti, K. L. Kolho, H. Nuutinen, U. Turunen, and M. Färkkilä, “Crohn’s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn’s disease activity index and endoscopic findings,” Inflammatory Bowel Diseases, vol. 14, pp. 40–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Sipponen, E. Savilahti, P. Karkkainen et al., “Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn’s disease,” Inflammatory Bowel Diseases, vol. 14, pp. 1392–1398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Buderus, J. Boone, D. Lyerly, and M. J. Lentze, “Fecal lactoferrin: a new parameter to monitor infliximab therapy,” Digestive Diseases and Sciences, vol. 49, pp. 1036–1039, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Kaiser, J. Langhorst, H. Wittkowski et al., “Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome,” Gut, vol. 56, pp. 1706–1713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Torun, B. D. Tunc, B. Suvak et al., “Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity,” Clinics and Research in Hepatology and Gastroenterology, vol. 36, pp. 491–497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Celikbilek, S. Dogan, O. Ozbakir et al., “Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis,” Journal of Clinical Laboratory Analysis, vol. 27, pp. 72–76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. E. Cherfane, L. Gessel, D. Cirillo, M. B. Zimmerman, and S. Polyak, “Monocytosis and a low lymphocyte to monocyte ratio are effective biomarkers of ulcerative colitis disease activity,” Inflammatory Bowel Diseases, vol. 21, pp. 1769–1775, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. K. Demir, A. Demirtas, S. U. Kaya et al., “The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis,” The Kaohsiung Journal of Medical Sciences, vol. 31, pp. 585–590, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Q. Gao, L. D. Huang, R. J. Dai, D. D. Chen, W. J. Hu, and Y. F. Shan, “Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn’s disease severity,” International Journal of Clinical and Experimental Pathology, vol. 8, pp. 14779–14785, 2015. View at Google Scholar
  17. F. Gomollon, A. Dignass, V. Annese et al., “3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management,” Journal of Crohn’s & Colitis, vol. 11, pp. 3–25, 2017. View at Google Scholar
  18. M. Yaman, U. Arslan, O. Beton, H. E. Pamukcu, and O. Dogdu, “Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio,” European Review for Medical and Pharmacological Sciences, vol. 20, pp. 912–918, 2016. View at Google Scholar
  19. T. Grenader, S. Nash, R. Adams et al., “Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study,” British Journal of Cancer, vol. 114, pp. 612–615, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Meisel, S. von Felten, D. R. Vogt et al., “Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): a post-hoc analysis of the TROPIC phase III trial,” European Journal of Cancer, vol. 56, pp. 93–100, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Liao, Z. W. Tang, D. W. Li, S. Q. Luo, P. Huang, and C. Y. Du, “Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report,” World Journal of Surgical Oncology, vol. 13, p. 265, 2015. View at Google Scholar
  22. A. Romano, N. L. Parrinello, M. L. Consoli et al., “Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents,” Annals of Hematology, vol. 94, pp. 1875–1883, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Guo, S. Zhang, Q. Zhang et al., “Neutrophil:lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin Chronic Low-Grade Systemic Inflammation and Health cohort study,” European Journal of Endocrinology, vol. 173, pp. 217–225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Ma, Y. Mao, X. He, Y. Sun, S. Huang, and J. Qiu, “The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism,” BMC Cardiovascular Disorders, vol. 16, p. 123, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Prodromidou, P. Andreakos, C. Kazakos, D. E. Vlachos, D. Perrea, and V. Pergialiotis, “The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer,” Inflammation Research, vol. 66, pp. 467–475, 2017. View at Publisher · View at Google Scholar
  26. N. Chen, W. Li, K. Huang et al., “Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies,” Oncotarget, vol. 8, pp. 32356–32369, 2017. View at Publisher · View at Google Scholar
  27. A. Erek Toprak, E. Ozlu, T. K. Uzuncakmak, E. Yalcınkaya, S. Sogut, and A. S. Karadag, “Neutrophil/Lymphocyte ratio, serum endocan, and nesfatin-1 levels in patients with psoriasis vulgaris undergoing phototherapy treatment,” Medical Science Monitor, vol. 22, pp. 1232–1237, 2016. View at Google Scholar
  28. M. K. Wlodarczyk, A. E. Sobolewska, K. Stec-Michalska, J. J. Fichna, and M. E. Wisniewska-Jarosinska, “Neutrophil-lymphocyte ratio in Crohn’s disease patients predicts sustained response to infliximab 52-week therapy,” Journal of Gastrointestinal and Liver Diseases, vol. 24, pp. 127-128, 2015. View at Google Scholar
  29. H. B. Lee, J. H. Kim, C. Y. Yim, D. G. Kim, and D. S. Ahn, “Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn’s disease,” The Korean Journal of Internal Medicine, vol. 12, pp. 7–15, 1997. View at Publisher · View at Google Scholar
  30. A. W. Segal, “How neutrophils kill microbes,” Annual Review of Immunology, vol. 23, pp. 197–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Catarzi, T. Marcucci, L. Papucci et al., “Apoptosis and Bax, Bcl-2, Mcl-1 expression in neutrophils of Crohn’s disease patients,” Inflammatory Bowel Diseases, vol. 14, pp. 819–825, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. T. T. MacDonald, I. Monteleone, M. C. Fantini, and G. Monteleone, “Regulation of homeostasis and inflammation in the intestine,” Gastroenterology, vol. 140, pp. 1768–1775, 2011. View at Publisher · View at Google Scholar · View at Scopus